About Motif Labs
Motif Labs is a company based in Aylmer (Canada) founded in 2017 by Mario Naric was acquired by Organigram in December 2024. Motif Labs offers products and services including BOXHOT, Rizzlers, DEBUNK, Boondocks, and Floe State. Motif Labs operates in a competitive market with competitors including MediPharm Labs, Holistic Industries, Vertosa, FarmaceuticalRX and ANANDA Scientific, among others.
- Headquarter Aylmer, Canada
- Founders Mario Naric
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Organigram
(Dec 06, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Motif Labs
Motif Labs offers a comprehensive portfolio of products and services, including BOXHOT, Rizzlers, DEBUNK, Boondocks, and Floe State.
Cannabinoid-infused product for consumer extraction needs.
Branded item for cannabinoid formulation and purification.
Product supporting extraction and industry applications.
Cannabis-related item for formulation processes.
Specialized product in cannabinoid extraction services.
People of Motif Labs
Unlock access to complete
Funding Insights of Motif Labs
Detailed funding history for Motif Labs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Motif Labs
Motif Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Organigram.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of cannabis products, brands, and international business development investments
|
Locked | Locked | Locked |
Investor details for Motif Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Motif Labs
Investment portfolio details for Motif Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Motif Labs
Detailed financials for Motif Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Motif Labs Comparisons
Peer comparison for Motif Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Motif Labs
Motif Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediPharm Labs, Holistic Industries, Vertosa, FarmaceuticalRX and ANANDA Scientific, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical-grade cannabinoid products and APIs are manufactured.
|
|
| Locked | Locked | Locked |
Proprietary medical cannabis strains are developed and offered.
|
|
| Locked | Locked | Locked |
Technology for active ingredients from infused hemp is provided.
|
|
| Locked | Locked | Locked |
Cannabis-based products including flower and concentrates are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Oral cannabis-based healthcare products are developed for therapeutic treatments.
|
Detailed competitors of Motif Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Motif Labs
Complete news archive for Motif Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Motif Labs
Motif Labs was founded in 2017.
Motif Labs is headquartered in Aylmer, Canada. It is registered at Aylmer, Quebec, Canada.
Mario Naric is the current CEO of Motif Labs. They have also founded this company.
Motif Labs was founded in 2017 and is based in Aylmer, Canada, within the cannabis industry. Cannabinoid extraction, purification, and formulation services are offered, including CO2 distillate production, vaporizer filling, pre-roll infusion, tincture filling, hydrocarbon extraction, CBN production, and isolate production. Brands that align with market requirements are curated by the company to support its operations.
Motif Labs's top competitors include Holistic Industries, MediPharm Labs and FarmaceuticalRX.
Motif Labs offers BOXHOT, Rizzlers, DEBUNK, Boondocks, and Floe State.
Motif Labs has 1 investor. Key investors include Organigram.